Norbert Žilka
Norbert Žilka is currently the director of the Institute of Neuroimmunology of the SAS, where he held several research positions from 1998 to 2020. He specializes in research in the field of neurodegenerative diseases of the human brain and the preclinical and clinical development of drugs that modify this disease.
Sign in to ITAPA Health&Care 2025
-
Discussion "Biobanks as an opportunity for personalised medicine"
-
DISCUSSION "How to support innovations in healthcare?"